MNPR
Monopar Therapeutics·NASDAQ
--
--(--)
--
--(--)
MNPR fundamentals
Monopar Therapeutics (MNPR) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.35 (YoY +30.00%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.35
+30.00%
Report date
Aug 12, 2025
Earnings Call
8:15 AM on Aug 12, 2025
Meeting link.EPS
Actual | -0.5 | -0.7 | -0.75 | -0.95 | -0.8 | -0.85 | -1 | -1.05 | -0.95 | -1.1 | -0.95 | -1.15 | -0.95 | -0.8 | -0.7 | -0.6 | -0.5 | -0.5 | -0.37 | -2.74 | -0.38 | -0.35 | |
Forecast | -0.55 | -0.85 | -0.7833 | -0.925 | -0.9333 | -0.9375 | -1.02 | -0.97 | -1.04 | -1.0333 | -1.0833 | -1.025 | -1.11 | -0.92 | -0.7667 | -0.8167 | -0.725 | -0.5 | -0.995 | -0.378 | -0.68 | -0.4583 | |
Surprise | 0.00% | +9.09% | +17.65% | +4.25% | -2.70% | +14.28% | +9.33% | +1.96% | -8.25% | +8.65% | -6.46% | +12.30% | -12.20% | +14.41% | +13.04% | +8.70% | +26.53% | +31.03% | 0.00% | +62.81% | -624.87% | +44.12% | +23.63% |
Revenue
Actual | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Monopar Therapeutics's revenue and profit?What is Monopar Therapeutics's gross profit margin?What is Monopar Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Monopar Therapeutics’s earnings call?What is the market's earnings forecast for Monopar Therapeutics next quarter?Did Monopar Therapeutics beat or miss consensus estimates last quarter?What does Monopar Therapeutics do and what are its main business segments?What guidance did Monopar Therapeutics's management provide for the next earnings period?
